We’re thrilled to announce a partnership with Scipher Medicine today to accelerate precision medicine and expand the Immunology Multimodal Network, advancing shared decision-making for patients with rheumatoid arthritis (RA). Scipher’s PrismRA® precision medicine diagnostic test identifies patients who are unlikely to respond to specific RA therapies, enabling personalized treatment decisions.
By integrating this data into the Atropos Evidence™ Network, clinicians utilizing Atropos Health’s evidence generating solutions such as Green Button™ and ChatRWD™–healthcare’s first AI-powered chat to database application that delivers real-world evidence in minutes–will have the opportunity to generate evidence from the Immunology Multimodal Network for clinical decision-making. This collaboration marks a significant step towards advancing precision medicine in rheumatology and improving the lives of patients with RA.